Cargando…
The Use of Panitumumab-IRDye800CW in a Novel Murine Model for Conjunctival Squamous Cell Carcinoma
PURPOSE: Conjunctival squamous cell carcinoma (SCC) is a sight-threatening ocular surface malignancy with the primary treatment modality being surgical resection. To evaluate surgical imaging modalities to improve surgical resection, we established a novel murine model for conjunctival SCC to demons...
Autores principales: | Youn, Gun Min, Case, Ayden G., Jarin, Trent, Li, BaoXiang, Swarup, Aditi, Naranjo, Andrea, Bou-Khalil, Charbel, Yao, Jacqueline, Zhou, Quan, Hom, Marisa E., Rosenthal, Eben L., Wu, Albert Y. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Association for Research in Vision and Ophthalmology
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9344218/ https://www.ncbi.nlm.nih.gov/pubmed/35895055 http://dx.doi.org/10.1167/tvst.11.7.23 |
Ejemplares similares
-
Safety of panitumumab-IRDye800CW and cetuximab-IRDye800CW for fluorescence-guided surgical navigation in head and neck cancers
por: Gao, Rebecca W., et al.
Publicado: (2018) -
Metastatic and sentinel lymph node mapping using intravenously delivered Panitumumab-IRDye800CW
por: Krishnan, Giri, et al.
Publicado: (2021) -
Fluorescence-guided craniotomy of glioblastoma using panitumumab-IRDye800
por: Zhou, Quan, et al.
Publicado: (2022) -
Near-Infrared Fluorescence Imaging of EGFR-Overexpressing Tumors in the Mouse Xenograft Model Using scFv-IRDye800CW and Cetuximab-IRDye800CW
por: Amini, Abolfazl, et al.
Publicado: (2022) -
EGFR-targeted intraoperative fluorescence imaging detects high-grade glioma with panitumumab-IRDye800 in a phase 1 clinical trial
por: Zhou, Quan, et al.
Publicado: (2021)